芪参益气滴丸联合比索洛尔对老年慢性心衰患者血管内皮功能及外周血单核细胞内TLR4/NF-κB mRNA水平的影响

doi:10.3969/j.issn.1671-7171.2021.10.035

Abstract
Figure/Table
References (0)
Related Citation (15)

[1] ŠPINAR J,ŠPINAROVáL,VÍTOVEC J.Pathophysiology,causes and epidemiology of chronic heart failure[J].Vnitr Lek,2018,64(9):834-838.
[2] SINGHANIA G,EJAZ A A,MCCULLOUGH P A,et al.Continuation of chronic heart failure therapies during heart failure hospitalization-a review[J].Rev Cardiovasc Med,2019,20(3):111-120.
[3] Loop MS,van Dyke MK,Chen L,et al.Low utilization of beta-blockers among medicare beneficiaries hospitalized for heart failure with reduced ejection fraction[J].J Card Fail,2019,25(5):343-351.
[4] 孔志明.芪参益气滴丸联合瑞舒伐他汀对慢性心力衰竭患者B型脑钠肽及相关细胞因子的影响[J].宁夏医科大学学报,2018,40(2):192-195.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.
[6] 孙涛,闫继锋.比索洛尔联合沙库巴曲缬沙坦在慢性心力衰竭中的应用[J].重庆医学,2020,49(4):610-613.
[7] TOYODA S, HARUYAMA A, INAMI S,et al. Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure[J].J Cardiol,2020,75(2):140-147.
[8] 张浩,王赫,顾磊,等.卡维地洛与比索洛尔对慢性阻塞性肺疾病合并心力衰竭患者心肺功能及生活质量的影响[J].医学临床研究,2019,36(1):62-64.
[9] 李健,周鑫玲.养心氏片联合比索洛尔治疗冠心病心力衰竭的临床研究[J].世界中医药,2019,14(12):3278-3281.
[10] 郑立文,刘晨,段英春,等.芪参益气滴丸治疗慢性心力衰竭疗效评价[J].吉林中医药,2018,38(10):1161-1163.
[11] 刘钊,王志强,张利云.美托洛尔联合稳心颗粒对慢性心衰患者血管内皮功能及MCF-6、PGI2水平的影响[J].心血管康复医学杂志,2018,27(1):69-72.
[12] 冯庆涛,杨静,张燕,等.参桂益心汤对慢性心力衰竭患者外周血单核细胞Toll样受体4/核转录因子-κB信号通路的影响[J].中国实验方剂学杂志,2017,23(23):146-151.